A discussion about menopause at work can fail in two ways: dismissing symptoms that need attention, or assuming an experienced professional has become less capable. The research supports a more specific question. Who is experiencing difficulties, what support do they want, and does the response improve health and working life without imposing a stereotype?
Key findings
4,440: respondents analyzed in the US workplace study published in 2023.
13.4%: respondents reporting a specified adverse work outcome attributed to menopause symptoms.
10.8%: respondents reporting missed work during the preceding 12 months. Among them, the median was three days.
Approximately $1.8 billion: the study’s modeled annual US losses associated with missed workdays.
The predominantly White, relatively highly educated sample was not representative of every working woman, senior executive, or HNW individual. The economic figure is an extrapolation, not an audited payroll total. [1]
A meaningful minority reported disruption
Source: Faubion and colleagues. Categories overlap and cannot be added together. The majority did not report the measured adverse work outcomes; that does not invalidate the experience of those who did. [1]
The result supports responsive support rather than a blanket assumption of impairment at a particular age. An organization should be able to acknowledge symptoms without making them the explanation for every workplace difficulty.
The billion-dollar estimate is not a company invoice
The $1.8 billion estimate translates reported absence into a modeled economic impact. It cannot establish losses for a particular employer simply by multiplying the number of midlife employees by an average salary. The original assumptions and population matter. [1]
| Number | Meaning | Not equivalent to |
|---|---|---|
| 4,440 | Analyzed respondents | A census of working women or leaders |
| 13.4% | At least one specified adverse work outcome | All women unable to work |
| 10.8% | Reported missed work attributed to symptoms | Permanent exit from employment |
| $1.8 billion | Modeled national impact of missed workdays | Observed losses at every company |
For a professional partnership or family business, the next step is to understand actual needs. A national estimate can prompt that conversation but should not replace a workplace assessment or predict an individual colleague’s performance.
The financial case also should not become the sole reason support matters. A person’s health and preferences deserve attention even when a particular economic return has not been calculated.
The clinical question is not hormones versus mental health
NICE distinguishes depressive symptoms from a diagnosed depressive disorder. Its menopause guidance considers relevant symptom management while also directing clinicians to depression guidance when depression is suspected or diagnosed. Menopause-specific cognitive behavioral therapy is an option for certain symptoms according to needs and preferences. [2]
The implication is to avoid a false choice. Not every midlife difficulty has one explanation, and menopause-associated symptoms do not make other assessment unnecessary. An employer’s conversation should not become a diagnosis.
Someone choosing private care can ask how sleep disruption, menopausal symptoms, depression, anxiety, and other possible contributors are considered. If more than one area needs attention, who coordinates the plan? The answer should explain clinical integration rather than promote one universal product or therapy.
Senior responsibility changes logistics, not the evidence
The study does not isolate founders or chief executives. It cannot show that seniority increases or reduces symptoms. The relevant client angle concerns access, decision-making, and support rather than an invented leadership-prevalence rate.
A senior professional may prefer flexible appointments, a confidential pathway, or advice about work demands. These are possibilities to discuss, not assumptions about everyone in that role. Resources can widen options without removing the need for appropriate assessment.
The standard should be consistent across roles: listen to the person’s concerns and distinguish support from a judgment about competence. A salary or title should not determine whether symptoms are taken seriously.
Support should not create a new label for employees
A poorly framed program could pressure people to share information they would rather keep private or treat normal variation as a performance concern. Access should be clear, while participation and disclosure remain appropriately controlled.
This is a program-design recommendation, not employment-law advice. Organizations operating across the UK, United States, Europe, and GCC need advice applicable to their circumstances. The same information-sharing assumption should not be imposed everywhere.
A clinical record, appointment confirmation, and request for a work adjustment are different kinds of information. The person should understand what is shared and why. Funding an appointment should not automatically mean receiving its detailed findings.
A policy announcement is not an outcome evaluation
The Menopause Society launched Making Menopause Work in September 2024, based on workplace consensus recommendations. The initiative is intended to improve understanding and support. Its existence does not quantify what a particular employer’s program changed in symptoms, quality of life, or retention. [3]
A useful evaluation defines the aim before measuring success. Easier access, better knowledge, fewer unwanted disclosures, reduced interference, and improved retention are different outcomes. Each needs a corresponding measure.
Attendance at a seminar shows participation, not improved health. Satisfaction can show a positive experience without establishing a clinical effect. A program can report both process and health outcomes without collapsing them into one success percentage.
What private care should measure
| Area | Useful information | Boundary |
|---|---|---|
| Assessment | Symptoms, timing, severity, and impact | Age alone is not an assessment |
| Health | Appropriate symptoms and quality-of-life measures | One improvement does not prove every domain improved |
| Work | Patient-defined interference and goals | Retention is not the only legitimate goal |
| Experience | Understanding, choice, and confidence | Satisfaction is not a clinical effect size |
| Continuity | Review and responsibility for changes | One consultation does not establish lasting benefit |
Some people want to remain in the same role; others make a considered change. A reporting framework should not define every career change as failure. Patient health and preferences matter alongside an employer’s objective.
Follow-up should also identify who was reached and what other care occurred. A favorable result among respondents cannot automatically be applied to every person who started treatment.
Currency conversion does not create local evidence
Converting the US cost estimate into pounds, euros, Swiss francs, or dirhams would change the currency, not the population. Employment patterns, wages, access, sample composition, and measurement assumptions would still differ.
A useful international study could use consistent questions in defined populations. It should record occupational level and working arrangements without treating country income as individual wealth. Missing local outcomes should remain gaps, not zero rates.
The 2023 sample’s composition also deserves attention. A broader study could examine different ethnic groups, occupations, and financial circumstances, including people no longer employed. A workforce-only sample may miss important experiences outside current jobs.
The leadership question deserves a better design
Leadership-specific research should identify actual responsibilities rather than infer them from education or income. A high earner is not necessarily a senior decision-maker, and a founder is not necessarily wealthy.
Following participants over time could show how symptoms, work experiences, and care change. That would be more informative than turning a one-time association into a forecast about someone’s future career.
No new study is claimed here. The existing evidence helps define the next questions while preserving the distinction between observed sample results, clinical guidance, and proposed evaluations.
Keep the person’s priorities in the evaluation
A support program should ask which difficulties matter to the person before selecting an outcome. Fewer missed days may be relevant, but it does not automatically show better sleep, reduced symptoms, or a more sustainable workload. Several measures can provide a clearer picture than one headline about attendance.
Equally, a person who changes working arrangements may be making a positive choice. A program should not label that outcome a failure simply because it does not maximize hours worked. The clinical aim and the organization’s preferred staffing result can be discussed without being treated as identical.
For a family business or professional partnership, this distinction makes support more credible. It leaves room for appropriate care without turning a natural life transition into an assumption about an individual’s capability or future contribution.
What the numbers cannot tell us
The percentages are not rates for every working woman or executive. The economic total is modeled, not audited spending. Menopause does not explain every midlife mental health concern, and the evidence does not justify mandatory disclosure or a uniform treatment plan.
The bottom line
Experienced professionals should be able to obtain appropriate care without being dismissed or stereotyped. The study makes disruption visible in a meaningful minority while showing why blanket assumptions are wrong. A provider should explain what it assessed, what changed, and what will be reviewed later.
For journalists
Key comparison: 13.4% reported an adverse work outcome and 10.8% missed work in the studied US sample.
Important caveat: overlapping outcomes from a selected sample, not universal leadership impairment.
Suggested attribution: THE BALANCE analysis of menopause-related workplace research and care-evaluation questions.
Methodology and sources
This narrative analysis separates self-reported findings, economic extrapolation, guidance, and program announcements. It reports no HNW-specific treatment effect or evaluation of an employer or clinic.
